{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:00:58Z","timestamp":1794009658979,"version":"4.8.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["NRF-2016R1A2B4012417"],"award-info":[{"award-number":["NRF-2016R1A2B4012417"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Anaplastic thyroid cancer (ATC) and advanced differentiated thyroid cancers (DTCs) show fatal outcomes, unlike DTCs. Here, we demonstrate mutational landscape of 27 ATCs and 86 advanced DTCs by massively-parallel DNA sequencing, and transcriptome of 13 ATCs and 12 advanced DTCs were profiled by RNA sequencing.\n                    <jats:italic>TERT<\/jats:italic>\n                    ,\n                    <jats:italic>AKT1<\/jats:italic>\n                    ,\n                    <jats:italic>PIK3CA<\/jats:italic>\n                    , and\n                    <jats:italic>EIF1AX<\/jats:italic>\n                    were frequently co-mutated with driver genes (\n                    <jats:italic>BRAF<\/jats:italic>\n                    <jats:sup>V600E<\/jats:sup>\n                    and\n                    <jats:italic>RAS<\/jats:italic>\n                    ) in advanced DTCs as well as ATC, but tumor suppressors (e.g.,\n                    <jats:italic>TP53<\/jats:italic>\n                    and\n                    <jats:italic>CDKN2A<\/jats:italic>\n                    ) were predominantly altered in ATC.\n                    <jats:italic>CDKN2A<\/jats:italic>\n                    loss was significantly associated with poor disease-specific survival in patients with ATC or advanced DTCs, and up-regulation of\n                    <jats:italic>CD274<\/jats:italic>\n                    (PD-L1) and\n                    <jats:italic>PDCD1LG2<\/jats:italic>\n                    (PD-L2). Transcriptome analysis revealed a fourth molecular subtype of thyroid cancer (TC), ATC-like, which hardly reflects the molecular signatures in DTC. Furthermore, the activation of JAK-STAT signaling pathway could be a potential druggable target in\n                    <jats:italic>RAS<\/jats:italic>\n                    -positive ATC. Our findings provide insights for precision medicine in patients with advanced TCs.\n                  <\/jats:p>","DOI":"10.1038\/s41467-019-10680-5","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T06:03:11Z","timestamp":1561356191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":252,"title":["Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer"],"prefix":"10.1038","volume":"10","author":[{"given":"Seong-Keun","family":"Yoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4603-1999","authenticated-orcid":false,"given":"Young Shin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0098-0873","authenticated-orcid":false,"given":"Eun Kyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinha","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwan Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyeongseo","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young A","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Wook","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Kyung","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Jae","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Yeon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7240-3744","authenticated-orcid":false,"given":"Jong-Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3671-6364","authenticated-orcid":false,"given":"Young Joo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Sun","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,24]]},"reference":[{"key":"10680_CR1","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","volume":"159","author":"Cancer Genome Atlas Research Network.","year":"2014","unstructured":"Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell 159, 676\u2013690 (2014).","journal-title":"Cell"},{"key":"10680_CR2","doi-asserted-by":"publisher","first-page":"e1006239","DOI":"10.1371\/journal.pgen.1006239","volume":"12","author":"SK Yoo","year":"2016","unstructured":"Yoo, S. K. et al. Comprehensive analysis of the transcriptional and mutational landscape of follicular and papillary thyroid cancers. PLoS Genet. 12, e1006239 (2016).","journal-title":"PLoS Genet."},{"key":"10680_CR3","first-page":"44","volume":"4","author":"XM Keutgen","year":"2015","unstructured":"Keutgen, X. M., Sadowski, S. M. & Kebebew, E. Management of anaplastic thyroid cancer. Gland Surg. 4, 44\u201351 (2015).","journal-title":"Gland Surg."},{"key":"10680_CR4","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nrendo.2017.76","volume":"13","author":"E Molinaro","year":"2017","unstructured":"Molinaro, E. et al. Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies. Nat. Rev. Endocrinol. 13, 644\u2013660 (2017).","journal-title":"Nat. Rev. Endocrinol."},{"key":"10680_CR5","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/cncr.20081","volume":"100","author":"A D\u2019Avanzo","year":"2004","unstructured":"D\u2019Avanzo, A. et al. Follicular thyroid carcinoma: histology and prognosis. Cancer 100, 1123\u20131129 (2004).","journal-title":"Cancer"},{"key":"10680_CR6","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1210\/jc.2005-2838","volume":"91","author":"C Durante","year":"2006","unstructured":"Durante, C. et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J. Clin. Endocrinol. Metab. 91, 2892\u20132899 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10680_CR7","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1210\/jc.2013-3842","volume":"99","author":"T Ibrahimpasic","year":"2014","unstructured":"Ibrahimpasic, T. et al. Outcomes in patients with poorly differentiated thyroid carcinoma. J. Clin. Endocrinol. Metab. 99, 1245\u20131252 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10680_CR8","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1172\/JCI85271","volume":"126","author":"I Landa","year":"2016","unstructured":"Landa, I. et al. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J. Clin. Invest. 126, 1052\u20131066 (2016).","journal-title":"J. Clin. Invest."},{"issue":"13","key":"10680_CR9","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1158\/1078-0432.CCR-18-0373","volume":"24","author":"Nikita Pozdeyev","year":"2018","unstructured":"Pozdeyev, N. et al. Genetic analysis of 779 advanced differentiated and anaplastic thyroid cancers. Clin. Cancer Res. 24, 3059\u20133068 (2018).","journal-title":"Clinical Cancer Research"},{"key":"10680_CR10","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature11404","volume":"489","author":"Cancer Genome Atlas Research N..","year":"2012","unstructured":"Cancer Genome Atlas Research N. Comprehensive genomic characterization of squamous cell lung cancers. Nature 489, 519\u2013525 (2012).","journal-title":"Nature"},{"key":"10680_CR11","doi-asserted-by":"publisher","first-page":"13768","DOI":"10.1073\/pnas.1606220113","volume":"113","author":"B Alaei-Mahabadi","year":"2016","unstructured":"Alaei-Mahabadi, B., Bhadury, J., Karlsson, J. W., Nilsson, J. A. & Larsson, E. Global analysis of somatic structural genomic alterations and their impact on gene expression in diverse human cancers. Proc. Natl Acad. Sci. USA 113, 13768\u201313773 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10680_CR12","doi-asserted-by":"crossref","first-page":"69638","DOI":"10.18632\/oncotarget.11922","volume":"7","author":"SH Jung","year":"2016","unstructured":"Jung, S. H. et al. Mutational burdens and evolutionary ages of thyroid follicular adenoma are comparable to those of follicular carcinoma. Oncotarget 7, 69638\u201369648 (2016).","journal-title":"Oncotarget"},{"key":"10680_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15533","volume":"8","author":"L Ye","year":"2017","unstructured":"Ye, L. et al. The genetic landscape of benign thyroid nodules revealed by whole exome and transcriptome sequencing. Nat. Commun. 8, 15533 (2017).","journal-title":"Nat. Commun."},{"key":"10680_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/ng.1031","volume":"44","author":"TA Graubert","year":"2011","unstructured":"Graubert, T. A. et al. Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Nat. Genet. 44, 53\u201357 (2011).","journal-title":"Nat. Genet."},{"key":"10680_CR15","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1101\/gr.133645.111","volume":"22","author":"YS Ju","year":"2012","unstructured":"Ju, Y. S. et al. A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing. Genome Res. 22, 436\u2013445 (2012).","journal-title":"Genome Res."},{"key":"10680_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6681","volume":"6","author":"PN Taylor","year":"2015","unstructured":"Taylor, P. N. et al. Whole-genome sequence-based analysis of thyroid function. Nat. Commun. 6, 5681 (2015).","journal-title":"Nat. Commun."},{"key":"10680_CR17","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1006\/bbrc.1998.9379","volume":"250","author":"M Hayashi","year":"1998","unstructured":"Hayashi, M. et al. Molecular cloning and characterization of human PDE8B, a novel thyroid-specific isozyme of 3\u2019,5\u2019-cyclic nucleotide phosphodiesterase. Biochem. Biophys. Res. Commun. 250, 751\u2013756 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10680_CR18","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1038\/ng.3438","volume":"47","author":"LJ Valentijn","year":"2015","unstructured":"Valentijn, L. J. et al. TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors. Nat. Genet. 47, 1411\u20131414 (2015).","journal-title":"Nat. Genet."},{"key":"10680_CR19","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nature14980","volume":"526","author":"M Peifer","year":"2015","unstructured":"Peifer, M. et al. Telomerase activation by genomic rearrangements in high-risk neuroblastoma. Nature 526, 700\u2013704 (2015).","journal-title":"Nature"},{"key":"10680_CR20","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415\u2013421 (2013).","journal-title":"Nature"},{"key":"10680_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2665-7","volume":"16","author":"JC Rubinstein","year":"2016","unstructured":"Rubinstein, J. C. et al. Shifting patterns of genomic variation in the somatic evolution of papillary thyroid carcinoma. BMC Cancer 16, 646 (2016).","journal-title":"BMC Cancer"},{"key":"10680_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/nar\/27.1.29","volume":"27","author":"H Ogata","year":"1999","unstructured":"Ogata, H. et al. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 27, 29\u201334 (1999).","journal-title":"Nucleic Acids Res."},{"key":"10680_CR23","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1177\/1947601911423030","volume":"2","author":"NM Kofler","year":"2011","unstructured":"Kofler, N. M. et al. Notch signaling in developmental and tumor angiogenesis. Genes Cancer 2, 1106\u20131116 (2011).","journal-title":"Genes Cancer"},{"key":"10680_CR24","doi-asserted-by":"publisher","first-page":"a006502","DOI":"10.1101\/cshperspect.a006502","volume":"2","author":"S Koch","year":"2012","unstructured":"Koch, S. & Claesson-Welsh, L. Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb. Perspect. Med. 2, a006502 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10680_CR25","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1002\/cncr.29934","volume":"122","author":"YS Song","year":"2016","unstructured":"Song, Y. S. et al. Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients. Cancer 122, 1370\u20131379 (2016).","journal-title":"Cancer"},{"key":"10680_CR26","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1530\/ERC-15-0533","volume":"23","author":"R Liu","year":"2016","unstructured":"Liu, R. & Xing, M. TERT promoter mutations in thyroid cancer. Endocr. Relat. Cancer 23, R143\u2013R155 (2016).","journal-title":"Endocr. Relat. Cancer"},{"key":"10680_CR27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/cen.13017","volume":"85","author":"DT Yin","year":"2016","unstructured":"Yin, D. T. et al. Clinicopathological significance of TERT promoter mutation in papillary thyroid carcinomas: a systematic review and meta-analysis. Clin. Endocrinol. 85, 299\u2013305 (2016).","journal-title":"Clin. Endocrinol."},{"key":"10680_CR28","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1126\/science.aab0015","volume":"348","author":"RJ Bell","year":"2015","unstructured":"Bell, R. J. et al. Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer. Science 348, 1036\u20131039 (2015).","journal-title":"Science"},{"key":"10680_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ccr.2014.07.014","volume":"26","author":"CF Davis","year":"2014","unstructured":"Davis, C. F. et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell 26, 319\u2013330 (2014).","journal-title":"Cancer Cell"},{"key":"10680_CR30","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1158\/1078-0432.CCR-10-2393","volume":"17","author":"M Endo","year":"2011","unstructured":"Endo, M. et al. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors. Clin. Cancer Res. 17, 3771\u20133782 (2011).","journal-title":"Clin. Cancer Res."},{"key":"10680_CR31","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.jtho.2017.01.028","volume":"12","author":"SW Aesif","year":"2017","unstructured":"Aesif, S. W. et al. Loss of p16(INK4A) expression and homozygous CDKN2A deletion are associated with worse outcome and younger age in thymic carcinomas. J. Thorac. Oncol. 12, 860\u2013871 (2017).","journal-title":"J. Thorac. Oncol."},{"key":"10680_CR32","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1158\/1078-0432.CCR-18-0663","volume":"25","author":"YS Song","year":"2019","unstructured":"Song, Y. S. et al. Aberrant thyroid-stimulating hormone receptor signaling increases VEGF-A and CXCL8 secretion of thyroid cancer cells, contributing to angiogenesis and tumor growth. Clin. Cancer Res. 25, 414\u2013425 (2019).","journal-title":"Clin. Cancer Res."},{"key":"10680_CR33","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1634\/theoncologist.2016-0310","volume":"22","author":"JA Elvin","year":"2017","unstructured":"Elvin, J. A. et al. Clinical benefit in response to palbociclib treatment in refractory uterine leiomyosarcomas with a common CDKN2A alteration. Oncologist 22, 416\u2013421 (2017).","journal-title":"Oncologist"},{"key":"10680_CR34","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1158\/1078-0432.CCR-10-2307","volume":"17","author":"GE Konecny","year":"2011","unstructured":"Konecny, G. E. et al. Expression of p16 and retinoblastoma determines response to CDK4\/6 inhibition in ovarian cancer. Clin. Cancer Res. 17, 1591\u20131602 (2011).","journal-title":"Clin. Cancer Res."},{"key":"10680_CR35","doi-asserted-by":"publisher","first-page":"11501","DOI":"10.1073\/pnas.1001613107","volume":"107","author":"WR Wiedemeyer","year":"2010","unstructured":"Wiedemeyer, W. R. et al. Pattern of retinoblastoma pathway inactivation dictates response to CDK4\/6 inhibition in GBM. Proc. Natl Acad. Sci. USA 107, 11501\u201311506 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10680_CR36","doi-asserted-by":"publisher","first-page":"42445","DOI":"10.18632\/oncotarget.6442","volume":"6","author":"M Duquette","year":"2015","unstructured":"Duquette, M. et al. Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model. Oncotarget 6, 42445\u201342467 (2015).","journal-title":"Oncotarget"},{"key":"10680_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0623-5","volume":"14","author":"S Farkona","year":"2016","unstructured":"Farkona, S., Diamandis, E. P. & Blasutig, I. M. Cancer immunotherapy: the beginning of the end of cancer? BMC Med. 14, 73 (2016).","journal-title":"BMC Med."},{"key":"10680_CR38","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","volume":"348","author":"NA Rizvi","year":"2015","unstructured":"Rizvi, N. A. et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science 348, 124\u2013128 (2015).","journal-title":"Science"},{"key":"10680_CR39","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1200\/JCO.2017.75.3384","volume":"36","author":"H Rizvi","year":"2018","unstructured":"Rizvi, H. et al. Molecular determinants of response to anti-Programmed Cell Death (PD)-1 and anti-Programmed Death-Ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing. J. Clin. Oncol. 36, 633\u2013641 (2018).","journal-title":"J. Clin. Oncol."},{"key":"10680_CR40","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1210\/jc.2016-3756","volume":"102","author":"AV Chintakuntlawar","year":"2017","unstructured":"Chintakuntlawar, A. V. et al. Expression of PD-1 and PD-L1 in anaplastic thyroid cancer patients treated with multimodal therapy: results from a retrospective study. J. Clin. Endocrinol. Metab. 102, 1943\u20131950 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10680_CR41","doi-asserted-by":"publisher","first-page":"9102","DOI":"10.1200\/JCO.2018.36.15_suppl.9102","volume":"36","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y., Marin-Acevedo, J. A., Azzouqa, A. G., Manochakian, R. & Lou, Y. Association of CDKN2A gene alteration with high expression of PD-L1. J. Clin. Oncol. 36, 9102\u20139102 (2018).","journal-title":"J. Clin. Oncol."},{"key":"10680_CR42","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1159\/000444804","volume":"83","author":"W Sterlacci","year":"2016","unstructured":"Sterlacci, W., Fiegl, M., Droeser, R. A. & Tzankov, A. Expression of PD-L1 identifies a subgroup of more aggressive non-small cell carcinomas of the lung. Pathobiology 83, 267\u2013275 (2016).","journal-title":"Pathobiology"},{"key":"10680_CR43","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1089\/thy.2016.0147","volume":"26","author":"DY Lee","year":"2016","unstructured":"Lee, D. Y. et al. Recurrence and survival after gross total removal of resectable undifferentiated or poorly differentiated thyroid carcinoma. Thyroid 26, 1259\u20131268 (2016).","journal-title":"Thyroid"},{"key":"10680_CR44","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1089\/thy.2015.0316","volume":"26","author":"DY Lee","year":"2016","unstructured":"Lee, D. Y. et al. Changes of clinicopathologic characteristics and survival outcomes of anaplastic and poorly differentiated thyroid carcinoma. Thyroid 26, 404\u2013413 (2016).","journal-title":"Thyroid"},{"key":"10680_CR45","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1097\/PAS.0b013e3180309e6a","volume":"31","author":"M Volante","year":"2007","unstructured":"Volante, M. et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am. J. Surg. Pathol. 31, 1256\u20131264 (2007).","journal-title":"Am. J. Surg. Pathol."},{"key":"10680_CR46","unstructured":"DeLellis, R. A., Organitzacio\u0301 Mundial de la, S, International Agency for Research on C. Pathology and Genetics of Tumours of Endocrine Organs, 3rd edn (IARC Press, 2004)."},{"key":"10680_CR47","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows\u2013Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"10680_CR48","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491\u2013498 (2011).","journal-title":"Nat. Genet."},{"key":"10680_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5846","volume":"5","author":"N Stransky","year":"2014","unstructured":"Stransky, N., Cerami, E., Schalm, S., Kim, J. L. & Lengauer, C. The landscape of kinase fusions in cancer. Nat. Commun. 5, 4846 (2014).","journal-title":"Nat. Commun."},{"key":"10680_CR50","doi-asserted-by":"crossref","first-page":"11242","DOI":"10.18632\/oncotarget.3593","volume":"6","author":"V Costa","year":"2015","unstructured":"Costa, V. et al. New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma. Oncotarget 6, 11242\u201311251 (2015).","journal-title":"Oncotarget"},{"key":"10680_CR51","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"10680_CR52","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq\u2014a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169 (2015).","journal-title":"Bioinformatics"},{"key":"10680_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"10680_CR54","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739\u20131740 (2011).","journal-title":"Bioinformatics"},{"key":"10680_CR55","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie, D. A. et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462, 108\u2013112 (2009).","journal-title":"Nature"},{"key":"10680_CR56","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10680_CR57","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213\u2013219 (2013).","journal-title":"Nat. Biotechnol."},{"key":"10680_CR58","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).","journal-title":"Nucleic Acids Res."},{"key":"10680_CR59","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285\u2013291 (2016).","journal-title":"Nature"},{"key":"10680_CR60","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1093\/nar\/gkg509","volume":"31","author":"PC Ng","year":"2003","unstructured":"Ng, P. C. & Henikoff, S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 31, 3812\u20133814 (2003).","journal-title":"Nucleic Acids Res."},{"key":"10680_CR61","first-page":"20","volume":"Chapter 7, Unit","author":"I Adzhubei","year":"2013","unstructured":"Adzhubei, I., Jordan, D. M. & Sunyaev, S. R. Predicting functional effect of human missense mutations using PolyPhen-2. Curr. Protoc. Hum. Genet. Chapter 7, Unit 7, 20 (2013).","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"10680_CR62","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1093\/nar\/gkw520","volume":"44","author":"R Shen","year":"2016","unstructured":"Shen, R. & Seshan, V. E. FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. Nucleic Acids Res. 44, e131 (2016).","journal-title":"Nucleic Acids Res."},{"key":"10680_CR63","first-page":"e154","volume":"44","author":"R D\u2019Aurizio","year":"2016","unstructured":"D\u2019Aurizio, R. et al. Enhanced copy number variants detection from whole-exome sequencing data using EXCAVATOR2. Nucleic Acids Res. 44, e154 (2016).","journal-title":"Nucleic Acids Res."},{"key":"10680_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).","journal-title":"Genome Biol."},{"key":"10680_CR65","doi-asserted-by":"publisher","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","volume":"12","author":"E Talevich","year":"2016","unstructured":"Talevich, E., Shain, A. H., Botton, T. & Bastian, B. C. CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing. PLoS Comput Biol. 12, e1004873 (2016).","journal-title":"PLoS Comput Biol."},{"key":"10680_CR66","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1093\/bioinformatics\/btv408","volume":"31","author":"JS Gehring","year":"2015","unstructured":"Gehring, J. S., Fischer, B., Lawrence, M. & Huber, W. SomaticSignatures: inferring mutational signatures from single-nucleotide variants. Bioinformatics 31, 3673\u20133675 (2015).","journal-title":"Bioinformatics"},{"key":"10680_CR67","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"Consortium EP.","year":"2012","unstructured":"Consortium EP. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57\u201374 (2012).","journal-title":"Nature"},{"key":"10680_CR68","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","volume":"155","author":"D Hnisz","year":"2013","unstructured":"Hnisz, D. et al. Super-enhancers in the control of cell identity and disease. Cell 155, 934\u2013947 (2013).","journal-title":"Cell"},{"key":"10680_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2009-10-3-r25","volume":"10","author":"B Langmead","year":"2009","unstructured":"Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).","journal-title":"Genome Biol."},{"key":"10680_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."},{"key":"10680_CR71","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","volume":"153","author":"J Loven","year":"2013","unstructured":"Loven, J. et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153, 320\u2013334 (2013).","journal-title":"Cell"},{"key":"10680_CR72","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s004380050374","volume":"253","author":"GE Reyna-Lopez","year":"1997","unstructured":"Reyna-Lopez, G. E., Simpson, J. & Ruiz-Herrera, J. Differences in DNA methylation patterns are detectable during the dimorphic transition of fungi by amplification of restriction polymorphisms. Mol. Gen. Genet. 253, 703\u2013710 (1997).","journal-title":"Mol. Gen. Genet."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10680-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10680-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10680-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T14:23:53Z","timestamp":1694960633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10680-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,24]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["10680"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-10680-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,24]]},"assertion":[{"value":"31 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2764"}}